Saga Pharmaceuticals

We at Saga Pharmaceuticals believe that GCC, with a per capita income of USD (Dh 25,711) & growing exponentially year on year and with a population growing at 4% every year, has tremendous potential of buying technologically superior Western and European Food supplements, Drugs & Cosmetics. It is this potential and need that we at Saga Pharmaceuticals look to service. Due to its geographical location and past ambiguity in terms of regulations, leading pharmaceutical companies of the world were always skeptical about entering GCC market. Saga has the experience dealing with leading American and European pharmaceutical companies and is setting up its operational base in Saudi Arabia.